Hepatocellular Carcinoma Recurrence and Anesthesia

Overview

The investigators will verify the prognosis of hepatocellular carcinoma (HCC) according to the main anesthetic agents used for the general anesthesia.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: June 2019

Interventions

  • Other: Volatile anesthetics
  • Other: Intravenous anesthetics

Arms, Groups and Cohorts

  • Volatile
    • The investigators retrospectively reviewed and analyzed the electrical medical records of patients who underwent surgery for HCC under the general anesthesia using volatile anesthetics as maintenance agents.
  • Intravenous
    • The investigators retrospectively reviewed and analyzed the electrical medical records of patients who underwent surgery for HCC under the general anesthesia using intravenous anesthetics as maintenance agents.

Clinical Trial Outcome Measures

Primary Measures

  • Recurrence of HCC
    • Time Frame: Postoperative 2 year

Participating in This Clinical Trial

Inclusion Criteria

  • Patients undergoing surgery due to the HCC. Exclusion Criteria:

  • Patients undergoing re-operation due to the HCC. – Patients presenting distant metastasis. – Patients undergoing liver transplantation surgery.

Gender Eligibility: All

Minimum Age: 20 Years

Maximum Age: 100 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Seoul National University Bundang Hospital
  • Provider of Information About this Clinical Study
    • Principal Investigator: Hyo-Seok Na, Dr – Seoul National University Bundang Hospital

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.